LINETSKY DAVID (SVP, Life Sciences) sold 3.4% of their position (7.78K shares) of PHREESIA, INC. on the open market
Open‑market sale worth $127.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/20/2026ACC: 0001412408-26-000030
Officer· SVP, Life Sciences
Since Jul 2019
-7.78K
Net shares
Net seller
$127.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
7.78K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.74K
Price / share
$16.38
Trade value
$28.55K
% of position
0.8%
1/15/2026
231.72K→229.98K
Common Stock
Direct
Shares
−6.04K
Price / share
$16.36
Trade value
$98.76K
% of position
2.6%
1/16/2026
229.98K→223.94K
Total
Net shares
−7.78K
Net value
-$127.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/15/2026 | S · Sale | −1.74K | $16.38 | $28.55K | 0.8% | 231.72K | 229.98K |
| Common Stock Direct | 1/16/2026 | S · Sale | −6.04K | $16.36 | $98.76K | 2.6% | 229.98K | 223.94K |
| Total | −7.78K | -$127.31K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned9.79K
Total
9.79K indirect9.79K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.79K | Indirect |
| Total | 9.79K | 9.79K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported